Additionally, we observed that araliadiol increased VEGF levels through activation of the p38/PPAR-γ signaling pathway, producing effects comparable to minoxidil, a widely used treatment for both androgenetic alopecia and alopecia areata. This evidence concerns the gene VEGFA and alopecia areata.